The Biotech Growth Trust PLC (BIOG.L) LSE

Currency In GBp

AD

Valuation

Market Cap294.1M
Enterprise Value306.42M
P/E Ratio2.52
PEG Ratio0
Price/Sales Ratio2.01
Price/Book Ratio1.06
Enterprise/Revenue2.1
Enterprise/EBITDA2.16

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.96
Operating Margin0.98
AD

Management Effectiveness

Return On Assets0.43
Return On Equity0.48

Income Statement

Revenue137.16M
Revenue/Share6.33
Gross Profit132.52M
EBITDA131.43M
Net Income130.26M
Diluted EPS5.58

Balance Sheet

Total Cash0
Total Cash/Share0
Total Debt12.32M
Total Debt/Equity0.04
Current Ratio0.89
Book Value Per Share13.22

Price History

52-Week Change97.02
52-Week High1,469.19
52-Week Low701.63
Moving Average 50 Days1,306.42
Moving Average 200 Days1,220.43

Statistics

Average Volume60,925
Shares Outstanding19.31M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD